Clinical Trials · NCT00131469
Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Oregon Health and Science University
- Enrollment
- 79
- Start date
- Jun 2005
- Locations
- 3 sites, United States
- Primary endpoint
- Spine Bone Mineral Density (BMD)